Home/Filings/4/0001209191-23-058718
4//SEC Filing

Ho William Tai-Wei 4

Accession 0001209191-23-058718

CIK 0001740279other

Filed

Dec 14, 7:00 PM ET

Accepted

Dec 15, 8:24 AM ET

Size

13.2 KB

Accession

0001209191-23-058718

Insider Transaction Report

Form 4
Period: 2023-12-13
Ho William Tai-Wei
DirectorPRESIDENT AND CEO10% Owner
Transactions
  • Award

    Series A Warrants (right to buy)

    2023-12-13+81,96781,967 total
    Exercise: $1.25Exp: 2025-06-13Common Stock (81,967 underlying)
  • Award

    Common Stock

    2023-12-13+81,9672,421,512 total
  • Award

    Series B Warrants (right to buy)

    2023-12-13+81,96781,967 total
    Exercise: $1.50Exp: 2028-12-13Common Stock (81,967 underlying)
Holdings
  • Common Stock

    (indirect: By Children)
    72,999
  • Common Stock

    (indirect: By Children)
    73,000
  • Common Stock

    (indirect: See footnote)
    36,500
  • Common Stock

    (indirect: See footnote)
    36,500
  • Common Stock

    (indirect: See footnote)
    36,500
Footnotes (3)
  • [F1]The reported securities are included within 81,967 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock.
  • [F2]The shares are held by a relative of the Reporting Person. The Reporting Person has voting power pursuant to a voting proxy.
  • [F3]Fully vested and exercisable.

Issuer

IN8BIO, INC.

CIK 0001740279

Entity typeother

Related Parties

1
  • filerCIK 0001830914

Filing Metadata

Form type
4
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 8:24 AM ET
Size
13.2 KB